复杂型与无并发症急性B型主动脉夹层的腔内治疗
基于WL Gore全球腔内主动脉治疗注册研究,172例急性B型主动脉夹层患者接受胸主动脉腔内修复术(TEVAR),其中复杂型102例、无并发症型70例。
要点
- 复杂型B型夹层TEVAR累及分支血管比例更高,住院时间更长。
- 两组30天死亡率和主动脉并发症无显著差异。
- 无并发症型TEVAR的远期获益仍需随机试验验证。
核心结论
- TEVAR治疗复杂型与无并发症急性B型夹层的30天死亡率和围术期并发症均较低,中期结果良好。
- 无并发症急性B型夹层中TEVAR与药物治疗的角色需更长随访研究确定。
研究设计与样本
- 回顾性分析WL Gore全球腔内主动脉治疗注册研究中5014例患者,其中172例因急性B型主动脉夹层接受TEVAR。
- 复杂型102例,无并发症型70例。
临床怎么用
- TEVAR可作为复杂型急性B型夹层的一线治疗策略,并发症风险低。
- 无并发症急性B型夹层中选择TEVAR需权衡风险与获益,缺乏A级证据。
局限性
- 回顾性注册研究,非随机对照,存在选择偏倚。
- 无并发症组样本量较小(70例),随访时间有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The study objective was to analyze the outcomes of thoracic endovascular aortic repair performed for complicated and uncomplicated acute type B aortic dissections. METHODS: Patients from WL Gore's Global Registry for Endovascular Aortic Treatment who underwent thoracic endovascular aortic repair for acute type B aortic dissections were included, and data were retrospectively analyzed. RESULTS: Of 5014 patients enrolled in the Global Registry for Endovascular Aortic Treatment, 172 underwent thoracic endovascular aortic repair for acute type B aortic dissections. Of these repairs, 102 were for complicated acute type B aortic dissections and 70 were for uncomplicated acute type B aortic dissections. There were 46 (45.1%) procedures related to aortic branch vessels versus 15 (21.4%) in complicated type B aortic dissections and uncomplicated type B aortic dissections (P = .002). The mean length of stay was 14.3 ± 10.6 days (median, 11; range, 2-75) versus 9.8 ± 7.9 days (median, 8; range, 0-42) in those with complicated type B aortic dissections versus those with uncomplicated acute type B aortic dissections (P < .001). Thirty-day mortality was not different between groups (complicated type B aortic dissections 2.9% vs uncomplicated acute type B aortic dissections 1.4%, P = .647), as well as aortic complications (8.8% vs 5.7%, P = .449). Aortic event-free survival was 62.9% ± 37.1% versus 70.6% ± 29.3% at 3 years (P = .696). CONCLUSIONS: In the Global Registry for Endovascular Aortic Treatment, thoracic endovascular aortic repair results for complicated type B aortic dissections versus uncomplicated acute type B aortic dissections showed that 30-day mortality and perioperative complications were equally low for both. The midterm outcome was positive. These data confirm that thoracic endovascular aortic repair as the first-line strategy for treating complicated type B dissections is associated with a low risk of complications. Further studies with longer follow-up are necessary to define the role of thoracic endovascular aortic repair in uncomplicated acute type B dissections compared with medical therapy. However, in the absence of level A evidence from randomized trials, results of the uncomplicated acute type B aortic dissection patient cohort treated with thoracic endovascular aortic repair from registries are important to understand the related risk and benefit.
引用
- Spinelli D, Weaver FA, Azizzadeh A, et al. Endovascular treatment of complicated versus uncomplicated acute type B aortic dissection. J Thorac Cardiovasc Surg. 2021. PMID: 33612294. doi:10.1016/j.jtcvs.2021.01.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。